Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1cm): a prospective randomized study. J Am Coll Surg 2014; 218: 381-392.

Published: 13th November 2014

Authors: Yu W, Wang W, Rong W, Wang L, Xu Q, Wu F et al. et al.


There was no significant advantage from the radiotherapy in this study that included 119 patients. Five year recurrence-free survival was 36.9 per cent versus 16 per cent in controls (P=0.06). Likewise, overall five year survival was similar: 48.4 versus 37.2 per cent, respectively.

Pubmed Link

Your comments